LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholding for the Period Ended September 30, 2019
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliance Certificate For The Half Year Ended On September 30, 2019
Compliance Certificate under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 for the Half Year Ended On September 30, 2019. Lincoln Pharmaceuticals Ltd - 531633 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAHENDRA GULABDAS PATELDesignation :- Director LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lincoln Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Lincoln Pharmaceuticals Ltd - 531633 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting results and Scrutinizer''s Report for the 25th Annual General Meeting of the Company. LINCOLN PHARMACEUTICALS LTD. - 531633 - Closure of Trading Window
Pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 read with SEBI [Prohibition of Insider Trading] [Amendment] Regulations, 2018 and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by the Company it is informed that the Trading Window for dealing in securities of the Company shall remain closed from October 1, 2019 till 48 hours after the declaration of Financial Results of the Company for the Quarter and half year Ended on September 30, 2019. Lincoln Pharmaceuticals Ltd - 531633 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attached herewith the proceedings of 25th Annual General Meeting of the Company held on Monday, September 30, 2019. Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation of Scheme of Amalgamation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation of Scheme of Amalgamation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 LINCOLN PHARMACEUTICALS LTD. - 531633 - Outcome of Board Meeting
Intimation of Scheme of Amalgamation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015